Velan Capital Investment Management as of Sept. 30, 2023
Portfolio Holdings for Velan Capital Investment Management
Velan Capital Investment Management holds 28 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alimera Sciences Com New (ALIM) | 34.2 | $42M | 14M | 3.10 | |
| Praxis Precision Medicines I | 7.2 | $8.9M | 5.2M | 1.71 | |
| Heron Therapeutics (HRTX) | 5.8 | $7.2M | 7.0M | 1.03 | |
| Jasper Therapeutics | 5.5 | $6.8M | 11M | 0.61 | |
| Adma Biologics (ADMA) | 5.0 | $6.2M | 1.7M | 3.58 | |
| Quipt Home Medical Corporation Call Option (QIPT) | 5.0 | $6.1M | 1.2M | 5.09 | |
| Tela Bio (TELA) | 4.8 | $6.0M | 746k | 8.00 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 4.2 | $5.2M | 75k | 69.48 | |
| Optinose (OPTN) | 3.6 | $4.4M | 3.6M | 1.23 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 2.6 | $3.2M | 55k | 57.00 | |
| Inspire Med Sys (INSP) | 2.5 | $3.0M | 15k | 198.44 | |
| ImmunoGen | 2.4 | $3.0M | 190k | 15.87 | |
| Inspiremd (NSPR) | 2.4 | $3.0M | 904k | 3.27 | |
| Gossamer Bio (GOSS) | 2.1 | $2.6M | 3.1M | 0.83 | |
| Cabaletta Bio (CABA) | 1.9 | $2.3M | 150k | 15.22 | |
| Apellis Pharmaceuticals (APLS) | 1.5 | $1.9M | 50k | 38.04 | |
| Geron Corporation (GERN) | 1.3 | $1.7M | 779k | 2.12 | |
| Tenet Healthcare Corp Com New (THC) | 1.3 | $1.6M | 25k | 65.89 | |
| Icosavax | 1.0 | $1.2M | 161k | 7.75 | |
| Aslan Pharmaceuticals Spon Ads New (ASLN) | 1.0 | $1.2M | 625k | 1.88 | |
| Iovance Biotherapeutics Call Option (IOVA) | 0.9 | $1.1M | 250k | 4.55 | |
| Annexon (ANNX) | 0.9 | $1.1M | 460k | 2.36 | |
| Edesa Biotech | 0.7 | $810k | 1.3M | 0.63 | |
| Cullinan Oncology (CGEM) | 0.6 | $679k | 75k | 9.05 | |
| Inflarx Nv (IFRX) | 0.5 | $596k | 200k | 2.98 | |
| Rezolute Com New (RZLT) | 0.4 | $528k | 400k | 1.32 | |
| Inhibrx (INBX) | 0.4 | $459k | 25k | 18.35 | |
| Elevation Oncology (ELEV) | 0.3 | $330k | 497k | 0.66 |
